Although ICIs have demonstrated excellent efficacy, they also have been associated with unique irAEs.
Rebecca Zhou, PharmD Candidate, Jaehee Yang, PharmD Candidate
Advertisement
Articles by Rebecca Zhou, PharmD Candidate, Jaehee Yang, PharmD Candidate
Advertisement
Latest Updated Articles
Managing Toxicities Associated With Immune Checkpoint InhibitorsPublished: November 24th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
FDA Updates Boxed Warning for Cilta-Cel Following Reports of Immune Effector Cell–Associated Enterocolitis
3
Medetomidine: The Demon in the Illicit Fentanyl Supply
4
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
5
